Oral presentations Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

Advertisements

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

Approach to diagnosis of infective endocarditis

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes G. Kronvall, G. Kahlmeter, E.

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

S. M. Kotila, A. Virolainen, M. Snellman, S. Ibrahem, J. Jalava, O

K. Kümmerer, A. Henninger Clinical Microbiology and Infection

In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus A. Carricajo,

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes G. Kronvall, G. Kahlmeter, E.

Didier Guillemot, Claude Carbon Clinical Microbiology and Infection

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics

Potential risk factors for infection with Candida spp

Antibiotic susceptibility and genotypic characterization of Haemophilus influenzae strains isolated from nasopharyngeal specimens from children in day-care.

Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca N. Moustaoui,

Drug-resistant Salmonella enterica serotype Kentucky in Europe

Structure of grepafloxacin relative to activity and safety profile

Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia—a 7-year individual and population-based analysis A. Egli,

Late Breaking News Clinical Microbiology and Infection

Epidemiology of methicillin-resistant staphylococci in Europe

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Clinical Microbiology and Infection

Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany E. Raum, S. Lietzau,

Epidemiology of opportunistic infections in AIDS patients

Antibiotic usage and the incidence of resistance

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics J. Moira Greenhalgh,

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

L. Fenner, A. F. Widmer, A. Stranden, M. Conzelmann, A. Goorhuis, C

L. Vogel, E. van Oorschot, H.M.E. Maas, B. Minderhoud, L. Dijkshoorn

L. Arreaza, J.A. Vázquez Clinical Microbiology and Infection

MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.

Laboratory diagnosis of Clostridium difficile disease

Jacques Sirot, Patrice Courvalin, Claude-James Soussy

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Symposia and Oral Presentations

Outbreak of infection with high-level gentamicin-resistant Enterococcus faecalis (HLGRE) in a Norwegian hospital Ø. Wendelbo, R. Jureen, G.E. Eide, A.

Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology.

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Community-acquired pneumonia: epidemiologic and clinical consideration

P.M. Hawkey Clinical Microbiology and Infection

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock.

The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.

Fibronectin concentrations in catheter sepsis

Definition of the Clinical Antibacterial Spectrum of Activity

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species G. Kronvall, E. Holst Clinical Microbiology.

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

New oral cephalosporins in pediatric community-acquired infections

Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents Clinical Microbiology and Infection Volume.

Abstracts accepted for publication only

Modification of prescribers’ behavior: the Icelandic approach

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Typing of Clostridium difficile

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.

Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia—a 7-year individual and population-based analysis A. Egli,

Decision-making in otitis media in children, Part I: epidemiologic data and definitions for a reliable cost-effectiveness analysis Bernard Grenier Clinical.

Fernando Baquero, John F

J. Segreti Clinical Microbiology and Infection

Abstracts Clinical Microbiology and Infection

Clinical Microbiology and Infection

Presentation transcript:

Oral presentations Clinical Microbiology and Infection Clinical Microbiology and Infection Volume 16, Pages S1-S131 (April 2010) DOI: 10.1111/j.1469-0691.2010.03238.x Copyright © 2010 Terms and Conditions

Figure 1 PD interaction surface analysis: vancomycin & gentamicin departures from additivity. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Melting curve profiles of the tested Salmonella serotypes. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure Multiple logistic regression model for all ribotypes. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure Correlation between unit-specific antibiotic consumption and incidence of C. difficile. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Graphic 1 EASYMAG. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Clinical algorithm for antibiotic guidance in LRTI. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Pentraxin 3 peak plasma concentrations during meningococcal septic shock according to PTX3 genotype. Medians and interquartile ranges are presented. P value by Mann–Whitney test. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure Days to 3rd gen. cephalosporin susceptible isolate. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure Mean adherence rates to hand hygiene in the control and intervention group. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 YLL for gastrointestinal infections in Germany. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure Correlation of ciprofloxacin DDD with ciprofloxacin and β-lactam. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure The annual numbers of culture-positive specimens, the number of susceptibility tested cultures, the number of cultures suceptible to four drugs tested, the number of cultures resistant to at least one drug from 2001 to 2008. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10. 1111/j Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions

Figure 1 Serotype distribution and potential vaccine coverage. Clinical Microbiology and Infection 2010 16, S1-S131DOI: (10.1111/j.1469-0691.2010.03238.x) Copyright © 2010 Terms and Conditions